1-2 of 2
Yasushi Okuno
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib

Free
Ryohei Katayama, Luc Friboulet, Sumie Koike, Elizabeth L. Lockerman, Tahsin M. Khan, Justin F. Gainor, A. John Iafrate, Kengo Takeuchi, Makoto Taiji, Yasushi Okuno, Naoya Fujita, Jeffrey A. Engelman, Alice T. Shaw
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (22): 5686–5696.
https://doi.org/10.1158/1078-0432.CCR-14-1511
Published: 13 November 2014
View article titled, Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib
Open the PDF for Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib in another window
Includes: Supplementary data
Journal Articles

Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer

Free
Hiroaki Kawanishi, Yoshiyuki Matsui, Masaaki Ito, Jun Watanabe, Takeshi Takahashi, Koji Nishizawa, Hiroyuki Nishiyama, Toshiyuki Kamoto, Yoshiki Mikami, Yoshinori Tanaka, Giman Jung, Hideo Akiyama, Hitoshi Nobumasa, Parry Guilford, Anthony Reeve, Yasushi Okuno, Gozoh Tsujimoto, Eijiro Nakamura, Osamu Ogawa
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (9): 2579–2587.
https://doi.org/10.1158/1078-0432.CCR-07-1922
Published: 01 May 2008
View article titled, Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer
Open the PDF for Secreted CXCL1 Is a Potential Mediator and Marker of the Tumor Invasion of Bladder Cancer in another window
Includes: Supplementary data